Robin Bartolini

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Journal: JACC. CardioOncology

Published: September 04, 2025

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 07, 2025

ACKR2 aids the regulation of bone marrow eosinophils to promote monocyte differentiation and anti-bacterial immunity.

ACKR2 aids the regulation of bone marrow eosinophils to promote monocyte differentiation and anti-bacterial immunity.

Journal: Nature communications

Published: November 28, 2024

Correction: CCR1 and CCR2 Coexpression on Monocytes Is Nonredundant and Delineates a Distinct Monocyte Subpopulation.

Correction: CCR1 and CCR2 Coexpression on Monocytes Is Nonredundant and Delineates a Distinct Monocyte Subpopulation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 09, 2024

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 09, 2024

Inflammatory chemokine receptors CCR1, CCR2, CCR3 and CCR5 are essential for an optimal T cell response to influenza.

Inflammatory chemokine receptors CCR1, CCR2, CCR3 and CCR5 are essential for an optimal T cell response to influenza.

Journal: Mucosal immunology

Published: September 04, 2024

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 10, 2024

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

Journal: Oncology

Published: January 14, 2024

CCR1 and CCR2 Coexpression on Monocytes Is Nonredundant and Delineates a Distinct Monocyte Subpopulation.

CCR1 and CCR2 Coexpression on Monocytes Is Nonredundant and Delineates a Distinct Monocyte Subpopulation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 03, 2024

Enhanced CCR2 expression by ACKR2-deficient NK cells increases tumoricidal cell therapy efficacy.

Enhanced CCR2 expression by ACKR2-deficient NK cells increases tumoricidal cell therapy efficacy.

Journal: Journal of leukocyte biology

Published: January 03, 2024

Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.

Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.

Journal: Translational oncology

Published: July 11, 2023

M1/M2 macrophages and their overlaps - myth or reality?

M1/M2 macrophages and their overlaps - myth or reality?

Journal: Clinical science (London, England : 1979)

Published: April 14, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026